Corcept (CORT) Form 144: Insider sales reported

Corcept Therapeutics Inc. submitted a Form 144 notice relating to proposed sales of common stock.

Rhea-AI Filing Summary

Corcept Therapeutics Inc. submitted a Form 144 notice relating to proposed sales of common stock. The filing lists a stock option exercise dated 07/06/2022 and broker information for Stifel Nicolaus & Company. It also records recent dispositions by Joseph K. Belanoff of 26,198 shares on 03/25/2026 for $1,311,825 and 40,000 shares on 05/01/2026 for $2,003,858.

Key Figures

Sale by Joseph K. Belanoff: 26,198 shares Proceeds from 03/25/2026 sale: $1,311,825 Sale by Joseph K. Belanoff: 40,000 shares +3 more

6 metrics

Sale by Joseph K. Belanoff 26,198 shares sold on 03/25/2026

Proceeds from 03/25/2026 sale $1,311,825 03/25/2026 transaction

Sale by Joseph K. Belanoff 40,000 shares sold on 05/01/2026

Proceeds from 05/01/2026 sale $2,003,858 05/01/2026 transaction

Stock option exercise date 07/06/2022 Stock Option Exercise listed in filing

Broker reference (Stifel Nicolaus) 12837 (internal listing) Stifel Nicolaus & Company Inc. record

Key Terms

Form 144, Stock Option Exercise, Proceeds

3 terms

Form 144 regulatory

"submitted a Form 144 notice relating to proposed sales"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Stock Option Exercise financial

"Stock Option Exercise dated 07/06/2022"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Proceeds financial

"26198 | 1311825.00 and 40000 | 2003858.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Corcept Therapeutics' Form 144 (CORT) disclose?

It discloses a proposed resale filing and related details. The notice lists a stock option exercise dated 07/06/2022, broker information for Stifel Nicolaus, and two reported past sales by Joseph K. Belanoff of 26,198 and 40,000 shares.

How many shares did Joseph K. Belanoff sell recently for CORT?

The filing records two dispositions: 26,198 shares sold on 03/25/2026 for $1,311,825 and 40,000 shares sold on 05/01/2026 for $2,003,858. These amounts appear as proceeds tied to the listed transactions.

Does the Form 144 show the broker handling the sale for CORT?

Yes. The notice lists Stifel Nicolaus & Company Inc. with an address in St. Louis and references NASDAQ. The filing includes a broker record alongside the securities and transaction rows.

Is the filing an indication of an offering or a resale registration for CORT?

Form 144 is a notice of proposed resale under securities rules rather than a registration statement. It documents proposed or recent sales by an affiliate and related broker details rather than registering new shares for issuance.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/01/2026 - 11:40 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001286199
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CORCEPT THERAPEUTICS INC
SEC File Number	000-50679
Address of Issuer	101 REDWOOD SHORES PARKWAY REDWOOD CITY CALIFORNIA 94065
Phone	650.688.8803
Name of Person for Whose Account the Securities are To Be Sold	BELANOFF JOSEPH K
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Stifel Nicolaus & Company Inc. 501 N Broadway St. Louis MO 63102	12837	892043.00	107350000	06/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/06/2022	Stock Option Exercise	Corcept Therapeutics Inc.			12837	07/06/2022	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Joseph K. Belanoff 101 Redwood Shores Parkway Redwood City CA 94065	Common	03/25/2026	26198	1311825.00
Joseph K. Belanoff 101 Redwood Shores Parkway Redwood City CA 94065	Common	05/01/2026	40000	2003858.00

144: Remarks and Signature

Remarks
Date of Notice	06/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/26/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Toni Dobel, as a duly authorized representative of STIFEL, as attorney-in-fact for Joseph K. Belanoff
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)